key: cord-0716766-pvp2p76l authors: Lu, Yingying; Li, Yi; Deng, Wenyue; Liu, Mingyang; He, Yuanzhi; Huang, Lingyue; Lv, Mengxue; Li, Jianxin; Du, Hao title: Symptomatic Infection is Associated with Prolonged Duration of Viral Shedding in Mild Coronavirus Disease 2019: A Retrospective Study of 110 Children in Wuhan date: 2020-04-16 journal: Pediatr Infect Dis J DOI: 10.1097/inf.0000000000002729 sha: ce703b5a1af2e9d730b057b42ceb915fa1907422 doc_id: 716766 cord_uid: pvp2p76l Information regarding viral shedding in children with coronavirus disease 2019 (COVID-19) was limited. This study aims to investigate the clinical and laboratory characteristics associated with viral shedding in children with mild COVID-19. METHODS: The clinical and laboratory information of 110 children with COVID-19 at Wuhan Children’s Hospital, Wuhan, China, from January 30 to March 10, 2020, were analyzed retrospectively. RESULTS: The median age was 6 years old. The median period of viral shedding of COVID-19 was 15 days (interquartile range [IQR], 11–20 days) as measured from illness onset to discharge. This period was shorter in asymptomatic patients (26.4%) compared with symptomatic patients (73.6%) (11 days vs. 17 days). Multivariable regression analysis showed increased odds of symptomatic infection was associated with age <6 years (odds ratio [OR] 8.94, 95% confidence interval [CI]: 2.55–31.35; P = 0.001), hypersensitive C-reactive protein >3.0 mg/L (OR 4.89; 95% CI: 1.10–21.75; P = 0.037) and presenting pneumonia in chest radiologic findings (OR 8.45; 95% CI: 2.69–26.61; P < 0.001). Kaplan-Meier analysis displayed symptomatic infection (P < 0.001), fever (P = 0.006), pneumonia (P = 0.003) and lymphocyte counts <2.0 × 10(9)/L (P = 0.008) in children with COVID-19 were associated with prolonged duration of viral shedding in children with COVID-19. CONCLUSION: Prolonged duration of viral shedding in children with COVID-19 was associated with symptomatic infection, fever, pneumonia and lymphocyte count less than 2.0 × 10(9)/L. Monitoring of symptoms could help to know the viral shedding in children with COVID-19. , ferritin and procalcitonin) on admission. Chest radiologic findings were obtained on admission or the most obvious findings during hospitalization. The dates of illness onset, last exposure, diagnosis and discharge of patients were also recorded. Inpatients were discharge when they met the appropriate criteria, 2 one of which was testing negative for SARS-CoV-2 RNA by a throat or nasopharyngeal swab specimens two continuous times (with an interval time of more than 24 hours). Thus, we regarded the time from illness onset to discharge as the duration of viral shedding of SARS-CoV-2 in symptomatic children. Asymptomatic children came to the hospital due to an exposure history or abnormal chest radiologic imaging. Therefore, we regarded the time from dates of last exposure or abnormal chest radiologic imaging to discharge as the duration of viral shedding in asymptomatic children. Categoric variables were displayed as numbers and percentages. Continuous variables were presented as median (interquartile range [IQR]) and were compared using independent group t-tests when the data were distributed normally. The Mann-Whitney test was used when the data were not normally distributed. Categoric variables were compared using the χ 2 test or Fisher's exact test when the data were limited. Univariate and multivariate analyses with stepwise logistic regression were performed to identify risk factors for symptomatic infection. The cutoff point was selected from the median or quartile of each candidate risk factor. Prolonged duration of viral shedding was analyzed by the Kaplan-Meier method and the stratified log-rank statistic in different groups. Symptoms, abnormal laboratory markers, and pneumonia were used as potential factors affecting the duration of viral shedding, and the negative conversion of SARS-CoV-2 was selected as the event endpoint. Statistical analyses were performed using SPSS Software version 23.0. Statistical significance was defined as a two-sided P-value of less than 0.05. A total of 110 children with mild or ordinary COVID-19 were included in the current study, including 81 (73.6%) symptomatic patients and 29 (26.4%) asymptomatic patients. The median age of these patients was 6 years (range, 2 months to 15 years). An approximately 1.2:1.0 male-to-female ratio was found. In symptomatic patients, the most common symptoms were cough and dyspnea (51.8%), followed by fever (50.9%). Notably, 26 (23.6%) patients had digestive symptoms. All patients were administered antiviral therapy, of which interferon-α nebulization was the most frequently used. None of the patients required oxygen therapy. Detailed information is shown in Table 1 . Results from all patients were recorded on the date of admission to the hospital. Dynamic changes in laboratory findings were not performed because no deterioration of manifestations or radiologic results was observed in these patients. In all patients, a slightly increased level of neutrophils (8.2%), D-dimer (12.4%), hs-CRP (19.1%), procalcitonin (47.3%), IL-6 (8.2%), IL-10 (13.7%) and slightly decreased levels of neutrophils (7.3%), fibrinogen (37.8%), globulin (27.3%), CD4+/CD8+ T cell ratio (19.6%) and natural killer cells (26.1%) were observed ( Table 2) . We compared laboratory results between symptomatic patients and asymptomatic patients and found no difference except for slight anemia (P = 0.022), and slightly increased levels of aspartate aminotransferase (P = 0.004), which were observed only in symptomatic patients (Table 2) . The median duration of viral RNA shedding was 15 days (IQR 11-20 days), ranging from 5 to 37 days. The duration of viral shedding in symptomatic patients (17 [IQR 12-23]) was longer than that in asymptomatic patients (11) (12) (13) ). In Kaplan-Meier analysis, median age, symptoms, pneumonia, lymphocyte quartile and upper or lower range limits of laboratory markers were used as cutoff points for potential risk factors associated with prolonged duration of viral shedding. It was found that symptomatic infection (P < 0.001), fever (P = 0.006), pneumonia (P = 0.003) and lymphocyte counts <2.0 × 10⁹/L (P = 0.008) were associated with prolonged duration of viral shedding in children with COVID-19 ( Fig. 1 ). It was found that age younger than 6 years, lymphocyte counts <2.0 × 10⁹/L, globulin < 20.0 g/L, hs-CRP > 3.0 mg/L, procalcitonin > 0.05 ng/mL, IL-10 > 5.9 pg/mL, CD4+/CD8+ T cell ratio < 0.96 and pneumonia were associated with symptomatic infection in univariate analysis. In multivariate analysis, age younger than 6 years, hs-CRP beyond normal and pneumonia were independent risk factors for symptomatic infection in children with COVID-19 (Table 3 ). There were 64 (62.1%) patients who presented with pneumonia and these were more common in symptomatic patients (P < 0.001). The association between symptoms and pneumonia was evaluated using univariate analysis. It was found that symptomatic infection, fever, cough, dyspnea and digestive symptoms were correlated with pneumonia among children with COVID-19 (Table 4 ). Nevertheless, multivariate analysis showed no significant difference. In the present study, the median duration of SARS-CoV-2 RNA shedding was 15 days. Prolonged viral shedding was associated with fever, pneumonia and lymphocyte counts < 2.0 × 10⁹ in children with a mild and ordinary type of COVID-19. In addition, symptomatic infection was associated with an increased risk of pneumonia. Furthermore, younger age (<6 years) was an independent risk factor for symptomatic infection in children with COVID-19. In the current study, all the asymptomatic children at admission were mild or ordinary COVID-19, which is consistent with asymptomatic adults. 9 Upper respiratory specimens have shown higher viral loads in symptomatic adult patients soon after symptom onset, which gradually decreased. 6 In the present study, the duration of viral shedding in symptomatic children was significantly longer than in asymptomatic cases, which indicated that symptomatic patients had much more transmission potential and may need to be isolated. In reports of adult inpatients with COVID-19, most of them were symptomatic and presented with radiologic evidence of pneumonia. 10, 11 Invasive mechanical ventilation was associated with prolonged viral shedding in adult patients with SARS-CoV-2 infection. 12 In addition, higher viral RNA load and longer viral shedding of influenza A can be detected in lower respiratory tract specimens compared with upper respiratory tract specimens. 13 Therefore, patients with pneumonia might have a high viral load in lower respiratory tract specimens, and have longer for viral clearance times. In this study, symptomatic infection was more common in younger children. For young children who had an exposure history and presented fever, it is important to perform throat or (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) 17 (12-23) 11 (9-13) <0.001 NA, not available; IQR, interquartile range. Symptoms of digestive system included diarrhea, vomiting, poor feeding/anorexia and abdominal pain. Symptoms of central nervous system included headache. Symptoms of muscular system included malaise. nasopharyngeal swabs to confirm SARS-CoV-2 infection. It is worth noting that digestive symptoms such as diarrhea, vomiting, poor feeding and abdominal pain were not rare in children with COVID-19, which should not be ignored by parents and doctors. Children with COVID-19 experienced a milder clinical course than adults, and the majority of children recovered with interferon-α nebulization, similar to children with SARS. 14, 15 There are some limitations to this study. First, this was a retrospective study, and not all tests were performed and monitored during hospitalization in all patients. Second, all patients were diagnosed by throat or nasopharyngeal specimens using RT-PCR, but other specimens such as feces and urine were not monitored for SARS-CoV-2. Lastly, the ability to associate symptoms with duration of viral shedding might be limited by the sample size. We identified that prolonged duration of viral shedding was associated with fever, pneumonia and lymphocyte counts less than 2.0 × 10⁹/L in children with mild and ordinary COVID-19. World Health Organization. Coronavirus disease (COVID-2019) situation reports-51 National Health Commission of People's Republic of China. National Recommendations for Diagnosis and Treatment of COVID-19 (the 7th edition) Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study SARS-CoV-2 viral load in upper respiratory specimens of infected patients Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance Coronavirus disease (COVID-19) technical guidance: laboratory testing for 2019-nCoV in humans Clinical outcome of 55 asymptomatic cases at the time of hospital admission infected with SARS-Coronavirus-2 in Shenzhen Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Factors associated with prolonged viral RNA shedding in patients with COVID-19 Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia Other Members of the Hospital for Sick Children SARS Investigation Team. Children hospitalized with severe acute respiratory syndrome-related illness in Toronto Inflammatory cytokine profile in children with severe acute respiratory syndrome The authors thank all the healthcare providers at the confirmed isolation wards and technical assistance of the technicians in Wuhan Children's Hospital.